Nutrition, nutritional supplements and Parkinson's disease

Nutrition, nutritional supplements and Parkinson's disease
reference
Mischley LK, Lau RC, Bennett approx. The role of nutrition and nutritional supplements when Parkinson's disease progresses. oxid med Cell Longev . 2017; 2017: 6405278.
draft
This study was a cross-sectional analysis of an online platform created by the author (Laurie Mischley, ND, PhD). The platform takes Parkinson's patients into a longitudinal research study. The patients report on their Parkinson's symptoms, their dietary diary and the use of nutritional supplements.
participant
The study population included 1,053 people with idiopathic Parkinson's disease; 93 % of the participants were Caucasians, with an average of 5.2 years since the diagnosis.
study parameters evaluated
Parkinson's symptoms, severity of progression, nutrition (after recall) and taking nutritional supplements; The symptoms were assessed on the basis of the results reported by patients in the Parkinson's disease scale (Pro-PD), a result tool created by the author.
Primary result measurements
The analysis compares the disease progression rate of each patient with his diet and taking nutritional supplements to look for statistically significant contexts.
important knowledge
The following results show which food and nutritional supplements significantly ( p <0.05), which are associated with a slow progression or a faster progression of Parkinson's symptoms.
Delayed progress | faster progress |
fresh fruit and vegetables | fruit and vegetables in cans |
nuts and seeds | diet and non-diet soda |
non -fried fish | fried foods |
olive oil | beef |
wine | ice cream |
coconut oil | yogurt |
fresh herbs and spices | cheese |
Coenzyme Q10 | iron |
fish oil |
practice implications
Parkinson's disease is an extremely weak disease and is hardly understood. 1 conventional options are limited, and studies indicate that many Parkinson's patients of a diet, naturopathy and nutritional supplements are turning to slow down the disease. However, little is known about its effectiveness. The present study is an attempt to shed light on the effects of nutrition and taking nutritional supplements to the progress of Parkinson's disease.
Many of the results of this study are not too surprising. Most foods associated with a delayed progression are elements of a Mediterranean diet. This type of nutrition has an anti-inflammatory effect and is demonstrably associated with fewer cases and a later outbreak of Parkinson's disease. 3 Fischöl has repeatedly proven to be a neuroprotective 4 and in fact this study found a connection between fish consumption and a delayed progression of the Parkinson's symptoms.
Most foods associated with a delayed progression are elements of a Mediterranean diet.
The connection between consumption of canned goods and a faster progression of Parkinson's disease is fascinating. Since this connection also remained after adjustment of income, it is less likely that it will be associated with limited access to health care (which is often associated with low income status). Could there be something in the cans themselves? The authors postulate that bisphenol A (BPA) or aluminum, a well -known neurotoxin,
The association of lemonade consumption with a faster progression of the disease can be due to certain neurotoxins such as aspartame. 6 The association with fried foods can be related to lipid peroxidation. The association of ice cream, yogurt and cheese with quick progress is in line with previous research results; A meta-analysis of the absorption of dairy products and Parkinson's disease showed a dose-dependent connection between the absorption of dairy products and Parkinson's disease. 7 Both iron preparations and beef, which has a high iron load, were associated with a quick progression in this study, which corresponds to the assumption that iron due to its oxidative nature Symptom progression drives.
While Coenzyme Q10 (COQ10) was promising early in the Parkinson's disease, newer randomized controlled studies showed no benefits. 9 It is interesting that the connection between delayed progression and Coenzyme Q10 was no longer statistically significant in this study. The author postulates that COQ10, an expensive nutritional supplement, could be a replacement for a high income status that was associated with a delayed progression, possibly due to better access to health care. This study has some excellent strengths. The researchers adjusted all the results of age, gender, years since the diagnosis and income level, and the results give us the first indications of the effect of nutrition and nutritional supplements on Parkinson's disease. Of course there are also restrictions on this study. Conclusion from the study design are limited as a cross -sectional analysis. This study is a longitudinal study and this publication is temporary and does not claim to be complete. The researchers also not corrected the p values for multiple comparisons, so that it is possible that some statistically significant associations are wrong.
- Kalia LV, Lang ae. Parkinson's disease. lanzette . 2015; 386 (9996): 896-912.
- ren s, Cooper K, Cooper JA, Smith HT, Shaikh S. A systematic review and network meta-analysis of pharmacological therapies for patients with advanced Parkinson's disease. value heal . 2014; 17 (7): A390.
- Alcalay Rn, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The connection between compliance with the Mediterranean diet and Parkinson's disease. movement disord . 2012; 27 (6): 771-774.
- da Silva TM, Munhoz RP, Alvarez C, et al. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study for supplementation with omega-3 fatty acids. j affect disord . 2008; 111 (2-3): 351-359.
- Campdelacreu J. Parkinson's disease and Alzheimer's disease: environmental risk factors. neurology . 2014; 29 (9): 541-549.
- rycerz K, Jaworska-Adamu ever. Effects of aspartam metabolites on astrocytes and neurons. folia neuropathol . 2013; 51 (1): 10-17.
- Jiang W, Ju C, Jiang H, Zhang D. Accommodation of dairy products and risk of Parkinson's disease: a dose-effect meta analysis of prospective cohort studies. EUR J Epidemiol . 2014; 29 (9): 613-619.
- Medeiros MS, Schumacher-Schuh A, Cardoso Am, et al. Iron and oxidative stress in Parkinson's disease: an observation study on injury biomarkers. plus one . 2016; 11 (1): E0146129.
- Parkinson's study group QE3 Investigators, Beal MF, Oakes D, et al. A randomized clinical study with a high -dose Coenzyme Q10 at Parkinson's early stages: no useful detection. Jama Neurol . 2014; 71 (5): 543-552.